Neogen (NEOG)

• Market cap: $1.17B
• 1 day: -3.41%
• 5 days: 1.89%
• 1 month: -5.60%
• 3 months: -3.41%
• 6 months: -57.36%
• Year to date: -54.86%
• 1 year: -66.75%
• 5 years: -86.03%
• 10 years: -69.94%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.

Employees: 1,315

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

0% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 52

0% more repeat investments, than reductions

Existing positions increased: 116 | Existing positions reduced: 116

0.74% less ownership

Funds ownership: 119.74% [Q4 2024] → 119.0% (-0.74%) [Q1 2025]

2% less funds holding

Funds holding: 341 [Q4 2024] → 335 (-6) [Q1 2025]

29% less capital invested

Capital invested by funds: $3.15B [Q4 2024] → $2.24B (-$912M) [Q1 2025]

74% less call options, than puts

Call options by funds: $544K | Put options by funds: $2.07M

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $5 7% downside
• Avg. target: $7.50 39% upside
• High target: $10 86% upside

2 analyst ratings

• positive: 1 50%
• neutral: 1 50%
• negative: 0 0%

Guggenheim Subbu Nambi	86% upside $10	Buy Maintained	30 Jun 2025
Piper Sandler David Westenberg	7% downside $5	Neutral Maintained	22 Apr 2025